Geopolitics Alpha

Is Novartis (NVS) Outperforming Other Medical Stocks This Year?

Published . Updated .

Key takeaways

  • Here is how Novartis (NVS) and Alpha Cognition Inc.
  • Exposed: DIA, QQQ, IWM, RSP, VTI
  • Market reaction: QQQ −2.2% on the day (still updating); DIA −0.6% on the day (still updating)

Market Call

Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.

Get these market calls by email

The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.

Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.

Is Novartis (NVS) Outperforming Other Medical Stocks This Year?

Here is how Novartis (NVS) and Alpha Cognition Inc. (ACOG) have performed compared to their sector so far this year.

Directly affected

  • NVS Novartis Ag-4.2% 7d

    Named in this report.

  • ACOG Alpha Cognition+0.6% 7d

    Named in this report.

Indirectly affected

  • DIA SPDR Dow Jones Industrial Average ETF+0.3% 13d

    SPDR Dow Jones Industrial Average ETF: it is a broad US stock-market fund. Linked by “stocks” (the broad US market) in this story.

  • QQQ Invesco QQQ-9.8% 30d

    Invesco QQQ: it is a broad US stock-market fund. Linked by “stocks” (the broad US market) in this story.

  • XLV Health Care Select Sector SPDR

    Health Care Select Sector SPDR holds the health sector that Novartis AG belongs to, so it often moves with news about it.

  • AZN AstraZeneca+13.7% 30d

    AstraZeneca is a peer of Novartis AG in pharmaceutical preparations; rivals often move on the same news.

  • NVO Novo Nordisk A/S-0.1% 30d

    Novo Nordisk A/S is a peer of Novartis AG in pharmaceutical preparations; rivals often move on the same news.

  • GSK Gsk+0.7% 5d

    Gsk is a peer of Novartis AG in pharmaceutical preparations; rivals often move on the same news.

  • SNY Sanofi

    Sanofi is a peer of Novartis AG in pharmaceutical preparations; rivals often move on the same news.

  • ROIV Roivant Sciences+14.5% 18d

    Roivant Sciences is a peer of Novartis AG in pharmaceutical preparations; rivals often move on the same news.

Price reaction, T-5 to T+3

TickerT-5T-3T-1T0T+1T+2T+3
NVS+1.94%-0.11%base+1.30%after closeafter closeafter close
ACOGNo price data for this ticker———————
DIA+0.04%+0.26%base-0.57%after closeafter closeafter close
QQQ-0.18%+1.53%base-2.25%after closeafter closeafter close
XLV-0.28%+0.04%base+0.46%after closeafter closeafter close
AZN+2.66%+0.56%base+1.10%after closeafter closeafter close
NVO-0.56%-1.26%base+0.77%after closeafter closeafter close
GSK+2.17%+0.30%base+1.17%after closeafter closeafter close
SNY-0.53%+0.12%base+0.78%after closeafter closeafter close
ROIV+2.90%+5.90%base-0.08%after closeafter closeafter close

Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.

Is Novartis (NVS) Outperforming Other Medical Stocks This Year? Yahoo Finance

Source: Yahoo Finance

How far Spdr Dow Jones Industrial Average Etf Trust (DIA) has moved since 16 Nov 2026

CompanyWhenMoveStatus
AZNthat day+1.10%still updating
AZNthree days earlier+0.56%final price
AZNfive days earlier+2.66%final price
Spdr Dow Jones Industrial Average Etf Trust (DIA)that day-0.57%still updating
Spdr Dow Jones Industrial Average Etf Trust (DIA)three days earlier+0.26%final price
Spdr Dow Jones Industrial Average Etf Trust (DIA)five days earlier+0.04%final price
GSKthat day+1.17%still updating
GSKthree days earlier+0.30%final price
GSKfive days earlier+2.17%final price
NVOthat day+0.77%still updating
NVOthree days earlier-1.26%final price
NVOfive days earlier-0.56%final price
NVSthat day+1.30%still updating
NVSthree days earlier-0.11%final price
NVSfive days earlier+1.94%final price
Invesco Qqq Trust, Series 1 (QQQ)that day-2.25%still updating
Invesco Qqq Trust, Series 1 (QQQ)three days earlier+1.53%final price
Invesco Qqq Trust, Series 1 (QQQ)five days earlier-0.18%final price
ROIVthat day-0.08%still updating
ROIVthree days earlier+5.90%final price
ROIVfive days earlier+2.90%final price
SNYthat day+0.78%still updating
SNYthree days earlier+0.12%final price
SNYfive days earlier-0.53%final price
XLVthat day+0.46%still updating
XLVthree days earlier+0.04%final price
XLVfive days earlier-0.28%final price

Trades by members of Congress and officials in the stocks in this story

Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).

Who gains and who loses around Spdr Dow Jones Industrial Average Etf Trust (DIA)

Companies mentioned with this story

  • DIA Spdr Dow Jones Industrial Average Etf Trust

    For “Is Novartis (NVS) Outperforming Other Medical Stocks This Year?,” Spdr Dow Jones Industrial Average Etf Trust (DIA) is linked, with no stored direction, medium confidence. Reason on file: SPDR Dow Jones Industrial Average ETF: it is a broad US stock-market fund. Linked by “stocks” (the broad US market) in this story

  • QQQ Invesco Qqq Trust, Series 1

    Invesco Qqq Trust, Series 1 (QQQ) is linked, with no stored direction, medium confidence in the 16 Nov 2026 story “Is Novartis (NVS) Outperforming Other Medical Stocks This Year?.” Reason on file: Invesco QQQ: it is a broad US stock-market fund. Linked by “stocks” (the broad US market) in this story

  • IWM Ishares Tr

    For “Is Novartis (NVS) Outperforming Other Medical Stocks This Year?,” Ishares Tr (IWM) is linked, with no stored direction, medium confidence. Reason on file: iShares Russell 2000 ETF: it is a broad US stock-market fund. Linked by “stocks” (the broad US market) in this story

  • RSP Invesco Exchange Traded Fd T

    For “Is Novartis (NVS) Outperforming Other Medical Stocks This Year?,” Invesco Exchange Traded Fd T (RSP) is linked, with no stored direction, medium confidence. Reason on file: Invesco S&P 500 Equal Weight ETF: it is a broad US stock-market fund. Linked by “stocks” (the broad US market) in this story

  • VTI Vanguard Index Fds

    In “Is Novartis (NVS) Outperforming Other Medical Stocks This Year?,” Vanguard Index Fds (VTI) is linked, with no stored direction, medium confidence. Reason on file: Vanguard Total Stock Market ETF: it is a broad US stock-market fund. Linked by “stocks” (the broad US market) in this story

Spdr Dow Jones Industrial Average Etf Trust (DIA)

The 16 Nov 2026 story “Is Novartis (NVS) Outperforming Other Medical Stocks This Year?” names Spdr Dow Jones Industrial Average Etf Trust (DIA) because of this story.

For Spdr Dow Jones Industrial Average Etf Trust (DIA), the reason on file says SPDR Dow Jones Industrial Average ETF: it is a broad US stock-market fund. Linked by “stocks” (the broad US market) in this story

A second company, Invesco Qqq Trust, Series 1 (QQQ), is listed for a different reason: Invesco QQQ: it is a broad US stock-market fund. Linked by “stocks” (the broad US market) in this story

Dates and price levels for Spdr Dow Jones Industrial Average Etf Trust (DIA)

DIA traded between 507.92 and 522.62 across 8 sessions. The latest close on file is 515.65. IWM traded between 269.88 and 285.25 across 20 sessions. The latest close on file is 279.20. QQQ traded between 680.34 and 757.18 across 20 sessions. The latest close on file is 685.32.

A simple score for Spdr Dow Jones Industrial Average Etf Trust (DIA)

40 out of 100Price not final

“Is Novartis (NVS) Outperforming Other Medical Stocks This Year?” scores 40 out of 100. The score uses 1 sources, and 5 linked companies. The price is not final yet.